Long-term effect of depot medroxyprogesterone acetate on vaginal microbiota, epithelial thickness and HIV target cells

Journal of Infectious Diseases

Volumn 210, Issue 4, 2014, Pages 651-655

  Mitchell, Caroline M ^a,e   McLemore, Leslie ^a   Westerberg, Katharine ^a   Astronomo, Rena ^e   Smythe, Kimberly ^e   Gardella, Carolyn ^a   Mack, Matthias ^f   Magaret, Amalia ^b,e   Patton, Dorothy ^a   Agnew, Kathy ^a   McElrath, M Juliana ^b,c,d,e   Hladik, Florian ^a,c,e   Eschenbach, David ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Department of Laboratory Medicine ^*  (United States)

^c Division of Allergy and Infectious Disease   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

^e Fred Hutchinson Cancer Research Center   (United States)

^f UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

HIV; Medroxyprogesterone acetate; Vaginal mucosa

Indexed keywords

CHEMOKINE RECEPTOR CCR5; HLA DR ANTIGEN; MEDROXYPROGESTERONE ACETATE;

ADULT; ARTICLE; BACTERIAL COUNT; CD3+ T LYMPHOCYTE; CELL POPULATION; DRUG EFFECT; EPITHELIUM; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOHISTOLOGY; LACTOBACILLUS; LYMPHOCYTE COUNT; NORMAL HUMAN; PRIORITY JOURNAL; TARGET CELL; THICKNESS; VAGINA FLORA;

HIV; MEDROXYPROGESTERONE ACETATE; VAGINAL MUCOSA;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS, HORMONAL; DRUG IMPLANTS; EPITHELIUM; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MEDROXYPROGESTERONE ACETATE; MICROBIOTA; MUCOUS MEMBRANE; VAGINA; YOUNG ADULT;

EID: 84904492810     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu176     Document Type: Article

References (15)

1. UNAIDS. Global report: UNAIDS report on the global AIDS epidemic 2010. UNAIDS, Geneva, Switzerland, 2010.
2. Polis CB, Curtis KM. Use of hormonal contraceptives and HIV acquisition in women: a systematic review of the epidemiological evidence. Lancet Infect Dis 2013; 13: 797-808.
3. Population Division, U.D.o.E.S.A. World contraceptive use 2009. 2009. Available at: http: //www.un.org.offcampus.lib.washington.edu/esa/ population/publications/contraceptive2009/contracept2009-wallchart- front.pdf. Accessed 5 November 2013.
4. WHO. Hormonal contraception and HIV: technical statement. Geneva: World Health Organization, 2012.
5. Miller L, Patton DL, Meier A, Thwin S, Hooton TM, Eschenbach DA. Depomedroxyprogesterone-induced hypoestrogenism and changes in vaginal flora and epithelium. Obstet Gynecol 2000; 96: 431-9.
6. Patton DL, Thwin SS, Meier A, Hooton TM, Stapleton AE, Eschenbach DA. Epithelial cell layer thickness and immune cell populations in the normal human vagina at different stages of the menstrual cycle. Am J Obstet Gynecol 2000; 183: 967-73.
7. McElrath MJ, Smythe K, Randolph-Habecker J, et al. Comprehensive assessment of HIV target cells in the distal human gut suggests increasing HIV susceptibility toward the anus. J Acquir Immune Defic Syndr 2013; 63: 263-71.
8. Huijbregts RP, Helton ES, Michel KG, et al. Hormonal contraception and HIV-1 infection: medroxyprogesterone acetate suppresses innate and adaptive immune mechanisms. Endocrinology 2013; 154: 1282-95.
9. Marx PA, Spira AI, Gettie A, et al. Progesterone implants enhance SIV vaginal transmission and early virus load. Nat Med 1996; 2: 1084-9.
10. Chandra N, Thurman AR, Anderson S, et al. Depot medroxyprogesterone acetate increases immune cell numbers and activation markers in human vaginal mucosal tissues. AIDS Res Hum Retroviruses 2013; 29: 592-601.
11. Mauck CK, Callahan MM, Baker J, et al. The effect of one injection of Depo-Provera on the human vaginal epithelium and cervical ectopy. Contraception 1999; 60: 15-24.
12. Hild-Petito S, Veazey RS, Larner JM, Reel JR, Blye RP. Effects of two progestin-only contraceptives, Depo-Provera and Norplant-II, on the vaginal epithelium of rhesus monkeys. AIDS Res Hum Retroviruses 1998; 14: S125-30.
13. Saba E, Origoni M, Taccagni G, et al. Productive HIV-1 infection of human cervical tissue ex vivo is associated with the secretory phase of the menstrual cycle. Mucosal Immunol 2013; 6: 1081-90.
14. Martin HL, Richardson BA, Nyange PM, et al. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J Infect Dis 1999; 180: 1863-8.
15. Halpern V, Combes SL, Dorflinger LJ, Weiner DH, Archer DF. Pharmacokinetics of subcutaneous depot medroxyprogesterone acetate injected in the upper arm. Contraception 2014; 89: 31-5.